Summary
30.21 -0.03(-0.10%)10/04/2024
Simulations Plus Inc. (SLP)
Simulations Plus Inc. (SLP)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -0.20 | -4.28 | -12.69 | -22.16 | -36.48 | -27.92 | -12.04 | 2,688.56 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 30.21 | |
| Open | 30.56 | |
| High | 30.81 | |
| Low | 30.20 | |
| Volume | 58,579 | |
| Change | -0.06 | |
| Change % | -0.20 | |
| Avg Volume (20 Days) | 147,440 | |
| Volume/Avg Volume (20 Days) Ratio | 0.40 | |
| 52 Week Range | 29.95 - 51.22 | |
| Price vs 52 Week High | -41.02% | |
| Price vs 52 Week Low | 0.87% | |
| Range | -1.15 | |
| Gap Up/Down | 0.00 | |
Fundamentals | ||
| Market Capitalization (Mln) | 622 | |
| EBIDTA | 15,693,000 | |
| PE Ratio | 92.9615 | |
| PEG Ratio | 9.7712 | |
| WallStreet Target Price | 53.67 | |
| Book Value | 8.8590 | |
| Earnings Per Share | 0.5200 | |
| EPS Estimate Current Quarter | 0.1900 | |
| EPS Estimate Next Quarter | 0.0000 | |
| EPS Estimate Current Year | 0.6600 | |
| EPS Estimate Next Year | 0.8000 | |
| Diluted EPS (TTM) | 0.5200 | |
| Revenues | ||
| Profit Marging | 0.1626 | |
| Operating Marging (TTM) | 0.2427 | |
| Return on asset (TTM) | 0.0443 | |
| Return on equity (TTM) | 0.0616 | |
| Revenue TTM | 64,668,000 | |
| Revenue per share TTM | 3.2410 | |
| Quarterly Revenue Growth (YOY) | 0.1620 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 43,084,000 | |
| Dividends | ||
| Dividend Share | 0.2400 | |
| Dividend Yield | 0.0050 | |
| Valuations | ||
| Trailing PE | 92.9615 | |
| Forward PE | 69.4444 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 5.2514 | |
| Revenue Enterprise Value | 12.7146 | |
| EBITDA Enterprise Value | 50.2492 | |
| Shares | ||
| Shares Outstanding | 19,984,900 | |
| Shares Float | 16,210,988 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.11 | |
| Insider (%) | 18.79 | |
| Institutions (%) | 79.54 | |
08/26 12:00 EST - zacks.com
Simulations Plus (SLP) Restructures Business Unit Post-Acquisitions
Simulations Plus, Inc. SLP has streamlined its business unit and leadership structure to foster growth after recent acquisitions. These updates will be implemented on Aug 30, 2024.
Simulations Plus (SLP) Restructures Business Unit Post-Acquisitions
Simulations Plus, Inc. SLP has streamlined its business unit and leadership structure to foster growth after recent acquisitions. These updates will be implemented on Aug 30, 2024.
08/23 08:00 EST - businesswire.com
Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced strategic changes in leadership and the structure of its business units to optimize operations and support future growth.
Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced strategic changes in leadership and the structure of its business units to optimize operations and support future growth.
07/12 11:11 EST - zacks.com
Simulations Plus (SLP) Ties Up With ICCS for Chemical Safety
Simulations Plus, Inc. SLP has entered into a partnership with the International Collaboration on Cosmetics Safety (“ICCS”) to develop a physiologically-based kinetic (PBK) read-across strategy for diverse chemicals and exposure routes (intravenous, oral and dermal) across virtual populations of humans and rodents. This collaboration aims to establish procedural workflows and guidelines for integrating these methods into animal-free safety assessments.
Simulations Plus (SLP) Ties Up With ICCS for Chemical Safety
Simulations Plus, Inc. SLP has entered into a partnership with the International Collaboration on Cosmetics Safety (“ICCS”) to develop a physiologically-based kinetic (PBK) read-across strategy for diverse chemicals and exposure routes (intravenous, oral and dermal) across virtual populations of humans and rodents. This collaboration aims to establish procedural workflows and guidelines for integrating these methods into animal-free safety assessments.
07/05 09:12 EST - marketbeat.com
Simulations Plus Stock Drops 15% Despite EPS Beat
Simulations Plus NASDAQ: SLP is a small-cap healthcare technology company with a value of about $800 million. The firm has vastly underperformed the market and its sector over the last 12 months, with a total return of -7%.
Simulations Plus Stock Drops 15% Despite EPS Beat
Simulations Plus NASDAQ: SLP is a small-cap healthcare technology company with a value of about $800 million. The firm has vastly underperformed the market and its sector over the last 12 months, with a total return of -7%.
07/03 11:20 EST - zacks.com
Simulations Plus (SLP) Q3 Earnings & Revenues Beat Estimates
Simulations Plus' (SLP) fiscal third-quarter revenues are driven by strength in Software and Services units.
Simulations Plus (SLP) Q3 Earnings & Revenues Beat Estimates
Simulations Plus' (SLP) fiscal third-quarter revenues are driven by strength in Software and Services units.
07/03 08:53 EST - benzinga.com
Simulations Plus Posts Q3 Results, Joins First Foundation And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq futures falling around 0.2% on Wednesday.
Simulations Plus Posts Q3 Results, Joins First Foundation And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq futures falling around 0.2% on Wednesday.
07/02 19:28 EST - seekingalpha.com
Simulations Plus, Inc. (SLP) Q3 2024 Earnings Call Transcript
Simulations Plus, Inc. (NASDAQ:SLP ) Q3 2024 Earnings Conference Call July 2, 2024 5:00 PM ET Company Participants Lisa Fortuna - Investor Relations, Financial Profiles Shawn O'Connor - Chief Executive Officer Will Frederick - Chief Financial Officer & Chief Operating Officer Conference Call Participants Christine Rains - William Blair François Brisebois - Oppenheimer & Company Matt Hewitt - Craig-Hallum David Larsen - BTIG Operator Greetings, and welcome to the Simulations Plus Third Quarter Fiscal 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Simulations Plus, Inc. (SLP) Q3 2024 Earnings Call Transcript
Simulations Plus, Inc. (NASDAQ:SLP ) Q3 2024 Earnings Conference Call July 2, 2024 5:00 PM ET Company Participants Lisa Fortuna - Investor Relations, Financial Profiles Shawn O'Connor - Chief Executive Officer Will Frederick - Chief Financial Officer & Chief Operating Officer Conference Call Participants Christine Rains - William Blair François Brisebois - Oppenheimer & Company Matt Hewitt - Craig-Hallum David Larsen - BTIG Operator Greetings, and welcome to the Simulations Plus Third Quarter Fiscal 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
06/25 11:00 EST - zacks.com
Analysts Estimate Simulations Plus (SLP) to Report a Decline in Earnings: What to Look Out for
Simulations Plus (SLP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Simulations Plus (SLP) to Report a Decline in Earnings: What to Look Out for
Simulations Plus (SLP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
06/20 08:30 EST - businesswire.com
Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus CEO, Shawn O'Connor, will be participating in Morgan Stanley's 3rd Annual Life Sciences AI Summit on June 26, 2024, in New York City.
Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus CEO, Shawn O'Connor, will be participating in Morgan Stanley's 3rd Annual Life Sciences AI Summit on June 26, 2024, in New York City.
06/18 08:30 EST - businesswire.com
Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus will report 3rd quarter FY24 earnings and host a conference call to discuss the financial results on July 2, 2024, at 5pm EDT.
Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus will report 3rd quarter FY24 earnings and host a conference call to discuss the financial results on July 2, 2024, at 5pm EDT.
06/14 13:06 EST - zacks.com
Simulations Plus (SLP) Upgraded to Buy: Here's Why
Simulations Plus (SLP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Simulations Plus (SLP) Upgraded to Buy: Here's Why
Simulations Plus (SLP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
06/13 10:33 EST - zacks.com
Simulations Plus (SLP) Buys Pro-ficiency Holdings for $100M
Simulation Plus (SLP) acquires Pro-ficiency from QHP Capital for $100 million in an all-cash transaction.
Simulations Plus (SLP) Buys Pro-ficiency Holdings for $100M
Simulation Plus (SLP) acquires Pro-ficiency from QHP Capital for $100 million in an all-cash transaction.
06/12 08:58 EST - businesswire.com
QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus
RALEIGH, N.C.--(BUSINESS WIRE)--QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus.
QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus
RALEIGH, N.C.--(BUSINESS WIRE)--QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus.
06/12 08:00 EST - businesswire.com
Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced the acquisition of Pro-ficiency with simulation-enabled solutions to expand and enhance the Company's offerings.
Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced the acquisition of Pro-ficiency with simulation-enabled solutions to expand and enhance the Company's offerings.
05/22 08:30 EST - businesswire.com
Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus CEO, Shawn O'Connor, will be participating in Craig-Hallum's 21st Annual Institutional Investor Conference on May 29, in Minneapolis.
Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus CEO, Shawn O'Connor, will be participating in Craig-Hallum's 21st Annual Institutional Investor Conference on May 29, in Minneapolis.
05/16 14:21 EST - zacks.com
Simulations Plus (SLP) Launches GPX to Advance PBPK Modeling
Simulations Plus (SLP) unveils GastroPlus X, which significantly reduces time spent on model setup, data management, and reformatting results.
Simulations Plus (SLP) Launches GPX to Advance PBPK Modeling
Simulations Plus (SLP) unveils GastroPlus X, which significantly reduces time spent on model setup, data management, and reformatting results.
05/15 08:30 EST - businesswire.com
Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced the release of the completely redesigned GastroPlusX (GPX), the next generation PBPK/PBBM modeling & simulation software.
Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced the release of the completely redesigned GastroPlusX (GPX), the next generation PBPK/PBBM modeling & simulation software.
04/12 13:53 EST - investorplace.com
New AI Bot Predicts These 7 Stocks Will Mint Millionaires
You may have heard about GPT-4 Turbo, Gemini, Llama or X's (formerly Twitter) Grok. However, there is a new contender outside of these Big Tech models in town.
New AI Bot Predicts These 7 Stocks Will Mint Millionaires
You may have heard about GPT-4 Turbo, Gemini, Llama or X's (formerly Twitter) Grok. However, there is a new contender outside of these Big Tech models in town.
04/08 10:10 EST - zacks.com
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
For the seventh consecutive year, the FDA has renewed Simulations Plus' (SLP) license to the DILIsym software system for facilitating drug safety evaluations.
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
For the seventh consecutive year, the FDA has renewed Simulations Plus' (SLP) license to the DILIsym software system for facilitating drug safety evaluations.
04/04 08:30 EST - businesswire.com
U.S. FDA Renews DILIsym® Software Licenses for 7th Year
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced the US FDA has again renewed licenses to its DILIsym QST software to support informed decision-making in drug approvals.
U.S. FDA Renews DILIsym® Software Licenses for 7th Year
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced the US FDA has again renewed licenses to its DILIsym QST software to support informed decision-making in drug approvals.